Table.
Generic Drug Name | No. of Residents Prescribed Drug |
% of Total Prescriptions |
Type of Antipsychotic |
Duration of Use During 90-Day Stay in NH, Median (IQR), da |
---|---|---|---|---|
Quetiapine fumarate | 1 356 223 | 31.1 | Atypical | 72 (67–85) |
Risperidone | 1 061 897 | 24.4 | Atypical | 70 (50–83) |
Olanzapine | 570 453 | 13.1 | Atypical | 70 (48–83) |
Haloperidol | 402 077 | 9.2 | Conventional | 30 (7–70) |
Aripiprazole | 347 900 | 8.0 | Atypical | 69 (50–82) |
Clozapine | 232 125 | 5.3 | Atypical | 77 (67–85) |
Ziprasidone | 138 881 | 3.2 | Atypical | 66 (30–82) |
Chlorpromazine | 65 159 | 1.5 | Conventional | 30 (8–74) |
Fluphenazine | 54 867 | 1.3 | Conventional | 54 (26–76) |
All othersb | 109 141 | 2.9 | Atypical and conventional | 70 (52–83) |
Abbreviation: IQR, interquartile range.
Calculated among 186 076 residents of NHs receiving at least 1 antipsychotic and observed for at least 90 days.
Includes paliperidone, perphenazine, thiothixene, loxapine, trifluoperazine, combination of olanzapine and fluoxetine, asenapine, lloperidone, molindone, pimozine, trilafon, loxitane, and mesoridazine.